Modulation of the discriminative stimulus effects of d-amphetamine by mu and kappa opioids in squirrel monkeys

Pharmacology Biochemistry and Behavior

Volumn 65, Issue 1, 2000, Pages 43-51

  Powell, Kelly R ^a   Holtzman, Stephen G ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaine; d Amphetamine; Drug discrimination; Drug interactions; Enadoline; Morphine; Squirrel monkeys; U69,593

Indexed keywords

COCAINE; DEXAMPHETAMINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; ECOPIPAM; ENADOLINE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG POTENTIATION; NONHUMAN; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RECEPTOR BINDING; SQUIRREL MONKEY; TASK PERFORMANCE;

ANIMALS; BENZENEACETAMIDES; BENZOFURANS; COCAINE; DEXTROAMPHETAMINE; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MORPHINE; PYRROLIDINES; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; SAIMIRI;

EID: 0033970782     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00183-5     Document Type: Article

References (42)

1. Broadbent J., Appel J.B. The behavioral pharmacology of stimulants and hallucinogens. Drug discrimination and self-administration Balfour D.J.K. Psychotropic drugs of abuse. 1990;327-354 Pergamon Press, New York.
2. Broadbent J., Gaspard T.M., Dworkin S.I. Assessment of the discriminative stimulus effects of cocaine in the rat. Lack of interaction with opioids Pharmacol. Biochem. Behav. 51:1995;379-385.
3. Brown E.E., Finlay J.M., Wong J.T.F., Damsa G., Fibiger H.C. Behavioral and neurochemical interactions between cocaine and buprenorphine. Implications for the pharmacotherapy of cocaine abuse J. Pharmacol. Exp. Ther. 256:1991;119-126.
4. 2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine. Psychopharmacology (Berlin). 103:1991;50-55.
5. Carroll M.E., Lac S.T. Effects of buprenorphine on self-administration of cocaine and a non-drug reinforcer in rats. Psychopharmacology (Berlin). 106:1992;439-446.
6. Devine D.P., Leone P., Pocock D., Wise R.A. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release. In vivo microdialysis studies J. Pharmacol. Exp. Ther. 266:1993;1236-1246.
7. DiChiara G., Imperato A. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244:1988;1067-1080.
8. Dykstra L.A., Doty P., Johnson A.B., Picker M.J. Discriminative stimulus properties of cocaine, alone and in combination with buprenorphine, morphine and naltrexone. Drug Alcohol Depend. 30:1992;227-234.
9. Foltin R.W., Fischman M.W. The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans. J. Pharmacol. Exp. Ther. 261:1992;623-632.
10. Foltin R.W., Christiansen I., Levin F.R., Fischman M.W. Effects of single and multiple intravenous cocaine injections in humans maintained on methadone. J. Pharmacol. Exp. Ther. 275:1995;38-47.
11. Gerak L.R., France C.P. Discriminative stimulus effects of nalbuphine in rhesus monkeys. J. Pharmacol. Exp. Ther. 276:1996;523-531.
12. Greberman S.B., Wada K. Social and legal factors related to drug abuse in the United States and Japan. Public Health Rep. 109:1994;731-737.
13. Hemby S.E., Co C., Dworkin S.I., Smith J.E. Synergistic elevations in nucleus accumbens extracellular dopamine concentrations during self-administration of cocaine/heroin combinations (speedball) in rats. J. Pharmacol. Exp. Ther. 288:1999;274-280.
14. Jones D.N.C., Holtzman S.G. Interaction between opioid antagonists and amphetamine. Evidence for mediation by central delta opioid receptors J. Pharmacol. Exp. Ther. 262:1992;638-645.
15. Kamien J.B., Woolverton W.L. A pharmacological analysis of the discriminative stimulus properties of d-amphetamine in rhesus monkeys. J. Pharmacol. Exp. Ther. 248:1989;938-946.
16. Kimmel H.L., Holtzman S.G. Mu opioid agonists potentiate amphetamine- and cocaine-induced rotational behavior in the rat. J. Pharmacol. Exp. Ther. 282:1997;734-746.
17. Kleven M.S., Anthony E.W., Woolverton W.L. Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. J. Pharmacol. Exp. Ther. 254:1990;312-317.
18. Koetzner L., Riley A.L., Glowa J.R. Discriminative stimulus effects of dopaminergic agents in rhesus monkeys. Pharmacol. Biochem. Behav. 54:1996;517-523.
19. Kosten T.R., Rounsaville B.J., Gawin F.H., Kleber H.D. Cocaine abuse among opioid addicts. Demographic and diagnostic factors in treatment Am. J. Drug Alcohol Abuse. 12:1986;1-16.
20. Kreek M.J. Multiple drug use patterns and medical consequences. Meltzer H. Psychopharmacology, the third generation of progress. 1987;1597-1604 Raven Press, New York.
21. Kuzmin A.V., Semenova S., Gerrits M.A.F.M., Zvartau E.E., Van Ree J.M. κ-Opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice. Eur. J. Pharmacol. 321:1997;265-271.
22. Magura S., Kang S.Y., Nwakeze P.C., Demsky S. Temporal patterns of heroin and cocaine use among methadone patients. Subst. Use Misuse. 33:1998;2411-2467.
23. Maisonneuve I.M., Archer S., Glick S.D. U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats. Neurosci. Lett. 181:1994;57.
24. Mello N.A., Lukas S.E., Kamien J.B., Mendelson J.H., Drieze J., Cone E.J. The effects of chronic buprenorphine treatment on cocaine and food self-administration by rhesus monkeys. J. Pharmacol. Exp. Ther. 260:1992;1185-1193.
25. Mello N.A., Kamien J.B., Lukas S.E., Drieze J., Mendelson J.H. The effects of nalbuphine and butorphanol treatment on cocaine and food self-administration by rhesus monkeys. Neuropsychopharmacology. 8:1993;45-55.
26. Mello N.A., Negus S.S., Lukas S.E., Mendelson J.H., Sholar J.W., Drieze J. A primate model of polydrug abuse. Cocaine and heroin combinations J. Pharmacol. Exp. Ther. 274:1995;1325-1337.
27. A agonists. Behav. Pharmacol. 5:1994;591-598.
28. Negus S.S., Mello N.A., Portoghese P.S., Lin C. Effects of kappa opioids on cocaine self-administration by rhesus monkeys. J. Pharmacol. Exper. Ther. 282:1997;44-55.
29. Negus S.S., Gatch M.B., Mello N.K. Effects of mu opioid agonists alone and in combination with cocaine and d-amphetamine in rhesus monkeys trained to discriminate cocaine. Neuropsychopharmacology. 18:1998;325-338.
30. Riberdy A., Kantak K.M., Spealman R.D. Modulations of the discriminative stimulus effects of cocaine by the kappa agonist U-50,488. Soc. Neurosci. Abstr. 21:1995;718.
31. Schad C.A., Justice J.B., Holtzman S.G. Naloxone reduces the neurochemical and behavioral effects of amphetamine but not those of cocaine. Eur. J. Pharmacol. 275:1995;9-16.
32. Schad C.A., Justice J.B., Holtzman S.G. Differential effects of δ- and μ-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens. J. Neurochem. 67:1996;2292-2299.
33. Schottenfeld R.S., Pakes J.R., Oliveto A., Ziedonis D., Kosten T.R. Buprenorphine vs. methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch. Gen. Psychiatry. 54:1997;713-720.
34. Spanagel R., Herz A., Shippenberg T.S. The effects of opioid peptides on dopamine release in the nucleus accumbens. An in vivo microdialysis study J. Neurochem. 55:1990;1734-1740.
35. Spealman R.D., Bergman J. Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids. J. Pharmacol. Exp. Ther. 261:1992;607-615.
36. Spealman R.D., Bergman J. Opioid modulation of the discriminative stimulus effects of cocaine. Comparison of μ, κ and δ agonists in squirrel monkeys discriminating a low dose of cocaine Behav. Pharmacol. 5:1994;21-31.
37. Suzuki T., Mori T., Tsuji M., Maeda J., Kishimoto Y., Misawa M., Nagase H. Differential effects of μ-, δ- and κ-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats. Eur. J. Pharmacol. 324:1997;21-29.
38. Van Groll B.J., Appel J.B. Stimulus effects of d-amphetamine 1. DA mechanisms Pharmacol. Biochem. Behav. 43:1992;967-973.
39. Woolfolk D.R., Holtzman S.G. The effects of opioid receptor antagonism on the discriminative stimulus effects of cocaine and d-amphetamine in the rat. Behav. Pharmacol. 7:1996;779-787.
40. Woolfolk D.R., Holtzman S.G. μ-, δ- and κ-opioid receptor agonists do not alter the discriminative stimulus effects of cocaine or d-amphetamine in rats. Drug Alcohol Depend. 48:1997;209-220.
41. Woolverton W.L. Pharmacological analysis of the discriminative stimulus properties of d-amphetamine in rhesus monkeys. Pharmacologist. 26:1984;161.
42. Zaratin P., Clarke G.D. Comparative effects of selective κ-opioid receptor agonists on dopamine levels in the dorsal caudate of freely moving rats. Eur. J. Pharmacol. 264:1994;151-156.